Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Livedo reticularis during amantadine treatment.

Literature DB >> 5580722

Livedo reticularis during amantadine treatment.

Abstract

Livedo reticularis is a common side effect of treatment with amantadine for Parkinson's disease. Investigation of 40 such patients suggests that the livedo is a physiological response provoked by depletion of catecholamine stores in peripheral nerve terminals.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1971 PMID： 5580722 PMCID： PMC1796527 DOI： 10.1136/bmj.2.5762.627

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

2 in total

1. Livedo reticularis in patients with parkinsonism receiving amantadine.

Authors: C N Shealy; J B Weeth; D Mercier
Journal: JAMA Date: 1970-06-01 Impact factor: 56.272

2. Amantadine-dopamine interaction: possible mode of action in Parkinsonism.

Authors: R P Grelak; R Clark; J M Stump; V G Vernier
Journal: Science Date: 1970-07-10 Impact factor: 47.728

2 in total

7 in total

Review 1. The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review.

Authors: Markus Kraemer; Dieter Linden; Peter Berlit
Journal: J Neurol Date: 2005-08-26 Impact factor: 4.849

2. Livedo reticularis and related disorders.

Authors: Steven M Dean
Journal: Curr Treat Options Cardiovasc Med Date: 2011-04

3. Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes.

Authors: Amnon A Berger; Ariel Winnick; Jonathan Izygon; Binil M Jacob; Jessica S Kaye; Rachel J Kaye; Elisa E Neuchat; Adam M Kaye; Edward S Alpaugh; Elyse M Cornett; Andrew H Han; Alan D Kaye
Journal: Health Psychol Res Date: 2022-06-28

Review 4. Anti-parkinsonian drugs today.

Authors: N P Quinn
Journal: Drugs Date: 1984-09 Impact factor: 9.546